Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sch 42427

Known as: Sch-42427 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The topical antifungal Sch-39304 is a racemic compound comprised of two enantiomers, Sch-42427 and Sch-42426, only one of which… Expand
Is this relevant?
2002
2002
Genaconazole (SCH 39304) is a potent triazole antifungal agent that is active both orally and topically. Genaconazole is a… Expand
Is this relevant?
1995
1995
A series of azole derivatives carrying an N-acylmorpholine ring are described. The compounds were chemically designed to simulate… Expand
Is this relevant?
1994
1994
 
Is this relevant?
1993
1993
Paracoccidioidomycosis is characterized by depressed cellular but enhanced humoral immune responses, which suggests a Th2 type of… Expand
Is this relevant?
1992
1992
SCH 39304, a new triazole antifungal agent, is a 50:50 racemic mixture of two enantiomers, SCH 42427 and SCH 42426. The… Expand
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Concentrations of oral azoles in serum were compared in a single-dose pharmacologic study in mice. When hydroxypropyl-beta… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
1992
1992
SCH 39304 (304) and its isomers, SCH 42426 (426) and SCH 42427 (427), are new orally administered antifungal azole derivatives… Expand
  • table 1
  • table 2
Is this relevant?
Review
1992
Review
1992
Disseminated candidiasis is the most common life-threatening invasive fungal infection in granulocytopenic patients. A review of… Expand
Is this relevant?